Synergistic growth inhibiting effect of nitrous oxide and cycloleucine in experimental rat leukaemia
1984

Effects of Nitrous Oxide and Cycloleucine on Rat Leukaemia

Sample size: 8 publication Evidence: moderate

Author Information

Author(s): A.C.M. Kroes, J. Lindemans, J. Abels

Primary Institution: Institute of Haematology, Erasmus University

Hypothesis

Combining nitrous oxide with cycloleucine will enhance the inhibition of leukaemic growth in rats.

Conclusion

The combination of nitrous oxide and cycloleucine significantly reduces leukaemic growth more than either treatment alone.

Supporting Evidence

  • Combined treatment resulted in the strongest reduction of leukaemic infiltration in spleen and liver.
  • Peripheral leukocyte counts were lowest after combined treatment.
  • The deoxyuridine suppression test showed more severe disturbance with combined treatment.

Takeaway

Using a gas called nitrous oxide with a drug called cycloleucine helps to slow down cancer growth in sick rats.

Methodology

Male Brown Norway rats were treated with nitrous oxide, cycloleucine, or both, and their leukaemic growth was measured over 19 days.

Limitations

The study was conducted on a specific rat model, which may not fully represent human leukaemia.

Participant Demographics

Male Brown Norway rats aged 14-18 weeks.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication